BROOKE CHAVES: Open Payments
NPI 1003425745 · AVON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,098 in 90 payments from 15 companies in 2025. Trend: 2023 $125 · 2024 $992 · 2025 $2,098
Food & beverage: $2,098
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 17 | $494 |
| ABBVIE INC. | 20 | $352 |
| Janssen Biotech, Inc. | 9 | $259 |
| Madrigal Pharmaceuticals | 8 | $250 |
| Phathom Pharmaceuticals, Inc. | 13 | $238 |
| QOL Medical, LLC | 5 | $127 |
| Regeneron Healthcare Solutions, Inc. | 4 | $88 |
| PFIZER INC. | 4 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Novo Nordisk Inc | 2 | $44 |
Products named: IBSRELA, TREMFYA, REZDIFFRA, VOQUEZNA, SKYRIZI, Sucraid, DUPIXENT, LINZESS.
Industry payments across CT — which companies pay providers there.
